Iovance Biotherapeutics, Inc. (IOVA)
NASDAQ: IOVA · Real-Time Price · USD
14.09
-0.05 (-0.35%)
Oct 23, 2026, 4:00 PM EDT - Market closed
Iovance Biotherapeutics Stock Forecast
Stock Price Forecast
According to 10 analysts polled by S&P Global, Iovance Biotherapeutics stock has a consensus rating of "Buy" and an average price target of $14.4. The average 1-year stock price forecast is 2.20% higher than the current stock price, while the lowest is $7.00 (-50.32%) and the highest is $20 (+41.94%).
Price Target: $14.4 (+2.20%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Iovance Biotherapeutics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 6 | 6 | 5 | 5 | 6 | 6 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 2 | 2 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 10 | 10 | 9 | 9 | 10 | 10 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Jefferies | Jefferies | Buy Maintains $20 | Buy | Maintains | $20 | +41.94% | Oct 23, 2026 |
| Barclays | Barclays | Buy Maintains $15 → $18 | Buy | Maintains | $15 → $18 | +27.75% | Oct 13, 2026 |
| Robert W. Baird | Robert W. Baird | Hold Maintains $6 → $11 | Hold | Maintains | $6 → $11 | -21.93% | Oct 8, 2026 |
| Wells Fargo | Wells Fargo | Buy Reiterates $14 → $18 | Buy | Reiterates | $14 → $18 | +27.75% | Sep 30, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $20 | Buy | Reiterates | $20 | +41.94% | Sep 29, 2026 |
Financial Forecast
Revenue This Year
412.73M
from 263.50M
Increased by 56.63%
Revenue Next Year
593.63M
from 412.73M
Increased by 43.83%
EPS This Year
-0.45
from -1.09
EPS Next Year
-0.20
from -0.45
EPS and Forward PE are based on non-GAAP adjusted numbers.